methylene blue has been researched along with Cerebral Malaria in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Briolant, S; Desgrouas, C; Dormoi, J; Pradines, B | 2 |
Dormoi, J; Pradines, B | 1 |
3 other study(ies) available for methylene blue and Cerebral Malaria
Article | Year |
---|---|
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
Topics: Animals; Antimalarials; Atorvastatin; Disease Models, Animal; Drug Synergism; Female; Heptanoic Acids; Kaplan-Meier Estimate; Malaria, Cerebral; Methylene Blue; Mice; Mice, Inbred C57BL; Parasitemia; Pyrroles | 2013 |
Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Female; Malaria, Cerebral; Methylene Blue; Mice; Mice, Inbred C57BL; Plasmodium berghei | 2013 |
Dose responses of proveblue methylene blue in an experimental murine cerebral malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Erythrocytes; Female; Kaplan-Meier Estimate; Malaria, Cerebral; Methylene Blue; Mice; Mice, Inbred C57BL; Plasmodium berghei; Time Factors; Treatment Outcome | 2013 |